| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 700455 | Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- | 0.0220039422291539 | 0.405016 |
| NSC 710716 | Null | 0.0220039422291539 | 0.29088349 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0220039422291539 | 0.30189412 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0220039422291539 | 0.18139868 |
| NSC 728316 | 6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride | 0.0220039422291539 | 0.50318849 |
| NSC 736157 | Null | 0.0220039422291539 | 0.17269967 |
| NSC 736802 | Null | 0.0220039422291539 | 0.46859345 |
| NSC 737757 | 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole | 0.0220039422291539 | 0.26215067 |
| NSC 740 | Methotrexate | 0.0220039422291539 | 0.51699343 |
| NSC 746053 | Null | 0.0220039422291539 | 0.30802655 |